Reason for request
Extension of indication
Clinical Benefit
| Substantial |
Substantial in type 1 diabetes in children aged 2 to 5 years. |
Clinical Added Value
| no clinical added value |
LANTUS provides no improvement in actual benefit (IAB V, non-existent) in the management of children aged 2 to 5 years with type 1 diabetes. |
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
Kt9g4Lz2WEdyukRA
